Yeast Beta Glucan Market: Global Segments, Top Key Players, Size And Recent Trends By Forecast To 2034
The yeast beta glucan market is
expected to surge at 5.1% CAGR, reaching US$ 991.5
million by 2034. This growth is propelled by a heightened awareness of
overall well-being, underscored by the harmonious integration of natural
ingredients and sustainable practices.
The yeast beta glucan market is witnessing dynamic growth
fueled by the escalating demand for natural, functional, and sustainable
ingredients across diverse industries. Rising product demand in applications
such as animal feed and functional food is anticipated to be a key
market driver over the projected period.
The need for functional foods is growing
worldwide due to several variables, including the surging elderly population
and increasing prevalence of chronic diseases. Women and children are most
likely to have low immunity, particularly in developing nations. The market for
products that help increase immunity is predicted to rise due to growing
consumer knowledge of health issues.
Preventive regimens are becoming increasingly popular among
consumers, as opposed to post-treatment drugs. By 2034, product innovations,
especially in the nutrition sector, are expected to fuel demand for medications
and nutraceuticals containing yeast beta glucan.
Robust research & development activities and
collaborations among key players underscore a commitment to unlocking new
applications and formulations. With a focus on sustainability and clean-label
preferences, yeast beta glucan is poised to play a pivotal role in shaping the
future of health-centric and eco-conscious industries.
“Despite the product’s excellent nutritional value,
its compatibility with other culinary ingredients is difficult for
manufacturers. Furthermore, it is challenging for manufacturers to reduce the
chance of deterioration and maintain the nutritious composition during
processing.” – Nandini Roy Choudhury, Client Partner
at Future Market Insights
Information Source:
https://www.futuremarketinsights.com/reports/yeast-beta-glucan-market
Key Takeaways from the Yeast Beta Glucan Market Report:
- The
yeast beta glucan market is projected to grow at a CAGR of 5.1% during
the forecast period.
- The
United States yeast beta glucan market is expected to reach US$
166.1 million by 2034.
- Based
on type, the 1,3-glucan segment is expected to hold a market share
of 51.2% in 2024.
- China
is expected to surge at a CAGR of 8.1% from 2024 to 2034.
- The
United Kingdom is projected to rise at 5.1% CAGR through
the forecast period.
Competitive Landscape
Key Companies Profiled
- Cargill,
Incorporated
- EMD
Millipore
- Lallemand,
Inc.
- Van
Wankum Ingredients
- Biorigin
- Angel
Yeast Co., Ltd.
- Kerry
Group plc
- Leiber
- Lesaffre
Human Care
- Specialty
Biotech Co., Ltd.
Key companies are expanding their product portfolios and
employing advertising, partnerships, acquisitions, agreements, and mergers to
maintain market relevance and drive growth in the yeast beta glucan market.
For instance,
- In
2020, Angel Yeast expanded its yeast beta glucan production
capacity, responding to escalating product demand.
- In
December 2020, Lallemand Bio-Ingredients expanded its beta
glucans portfolio by acquiring Biotec BetaGlucans (BBG), a subsidiary of
ArticZymes Technologies.
Yeast Beta Glucan Market Segmentation by Category
By Type:
- 1,3-glucan
- 1,6-glucan
By Form:
- Soluble
- Insoluble
By End-use Application:
- Food
and Beverage Industry
- Cosmetics
and Skincare Industry
- Animal
Feed Industry
- Agriculture
Industry
- Pharmaceutical
By Region:
- North
America
- Latin
America
- Europe
- East
Asia
- South
Asia
- Oceania
- Middle
East and Africa
Comments
Post a Comment